• Company
  • Products & Services
  • R & D
  • News & Investors
  • Careers
  • Contact

Press Releases 2011

09.12.2011
Epigenomics AG Completes U.S. Clinical Validation Study for Colorectal Cancer Blood Test Epi proColon; Provides Update on U.S. Regulatory Plans
PDF 73 KB
 
16.11.2011
Epigenomics’ Licensee ARUP Presents Clinical Data for Colorectal Cancer Blood Test at AMP
PDF 48 KB
 
09.11.2011
Epigenomics AG Announces Q3 Financial Results and Operational Highlights
PDF 63 KB
 
07.11.2011
Open letter to the editor of “Clinical Gastroenterology and Hepatology” regarding a recently published article in that journal
PDF 77 KB
 
25.10.2011
Epigenomics announces the European launch of Epi proColon® 2.0 CE
PDF 65 KB
 
20.10.2011
SAVE THE DATE: Epigenomics - launch briefing on Epi proColon® 2.0 CE
PDF 54 KB
 
19.09.2011
Epigenomics AG reports Epi proColon® 2.0 finds 95% of cancers in clinical study
PDF 59 KB
 
10.08.2011
Epigenomics AG Presents Mid-Year Results and Announces Restructuring Plan Heightening Focus on the Key U.S. Market
PDF 111 KB
 
07.07.2011
Epigenomics AG: Surveys Show That Patients Believe in Blood Tests for Regular Colorectal Cancer Screening
PDF 124 KB
 
18.05.2011
Epigenomics AG to Suggest Reduction of Share Capital and 5:1 Reverse Stock Split at Upcoming AGM
PDF 38 KB
 
1-10 11-19 Next >
  • News & Media
    • Press Releases
      • 2011
      • 2010
      • 2009
      • Archive
    • Ad hoc Releases
    • Events
    • Downloads
    • Request Info
  • Investors
© Epigenomics AG 2011 | Imprint | Disclaimer | General Terms and Conditions | Data Protection Statement